SRPT has been in the news 563% more than usual
Sep 22, 2025, 6:31 PM
22.15%
What does SRPT do
Sarepta Therapeutics, based in Cambridge, Massachusetts, focuses on RNA-targeted therapeutics for rare diseases, particularly Duchenne muscular dystrophy, and has developed four approved products. The company employs 1,314 people and has about 40 programs in its pipeline.
SRPT has been in the news recently: Sarepta Therapeutics is not directly mentioned in the provided information. However, it is important to note that Metsera's stock surged after Pfizer announced its acquisition for $4.9 billion, expected to finalize in the fourth quarter. Additionally, Better Home & Finance experienced a 176% increase in stock value as it seeks to innovate the mortgage industry with AI technology.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.